Welcome to our dedicated page for DENTSPLY SIRONA news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on DENTSPLY SIRONA stock.
DENTSPLY SIRONA Inc. (symbol: XRAY) stands as the world’s largest manufacturer of professional dental products and technologies. As a global total solutions provider, Dentsply Sirona empowers dental professionals to offer better, safer, and faster dental care. The company’s extensive portfolio includes leading positions in consumables, equipment, technology, and specialty products. Dentsply Sirona is committed to innovation and quality, reflected in its comprehensive end-to-end solutions offering, which spans well-known and established brands in the industry.
Dentsply Sirona emerged from a merger between Dentsply International and Sirona Dental Systems in 2016. Today, the company manufactures and markets a complete range of dental and oral health products, including dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation.
Recently, Dentsply Sirona has announced enhancements to its DS Core platform, a cloud-based solution supporting dental professionals throughout the entire treatment continuum. The platform now boasts improved patient communication tools, a unified ordering system, and support for additional data formats, making it easier for dental practices to collaborate with labs and service providers.
Financially, Dentsply Sirona maintains a robust presence in the dental industry, with significant revenue generated through third-party distributors and direct sales to labs, offices, and consumers. The company’s ongoing commitment to innovation is further demonstrated by its DS World Las Vegas event, an annual gathering that provides dental professionals with market-leading education, networking opportunities, and exposure to the latest dental technologies.
With its headquarters in Charlotte, North Carolina, Dentsply Sirona continues to shape the future of dentistry, striving to enhance patient care and advance dental practices through its unwavering dedication to quality and innovation. For more information on Dentsply Sirona and its products, visit the official website.
Dentsply Sirona (Nasdaq: XRAY) has introduced Primescan 2, a cloud-native intraoral scanning solution powered by DS Core. This wireless scanner can operate on any internet-connected device, offering improved workflow efficiency and extended treatment capabilities compared to previous models. Key benefits include:
- Hardware-independence: Works on any device with an internet browser
- Versatility: Wireless and portable
- Simple handling: Sleeker design with narrower tip
- Fast workflow: Full arch scan in less than 1 minute
- Cloud storage: Reduces need for additional scan storage costs
- Always up-to-date: Automatic software updates via DS Core
Primescan 2 aims to enhance patient experience, support practice growth, and deliver simplicity, efficiency, and versatility to dental professionals.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in two upcoming investor conferences. The company will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 9:15 am ET, and the Baird Global Healthcare Conference on September 10, 2024, at 9:40 am ET.
Investors and other interested parties can access live audio webcasts and audio webcast replays of these presentations through the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. This participation in major healthcare conferences demonstrates Dentsply Sirona's commitment to engaging with investors and sharing insights about the company's performance and outlook in the dental industry.
Dentsply Sirona (Nasdaq: XRAY) has announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to take an executive position at another public company. The dental equipment manufacturer has initiated a search for a new CFO with the help of a leading executive search firm.
CEO Simon Campion praised Coleman's contributions over the past two years, highlighting his role in implementing the company's business transformation plan, initiating ERP modernization efforts, and supporting Employee Resource Groups. Coleman expressed pride in his accomplishments at Dentsply Sirona and confidence in the company's future success under its current leadership team.
Dentsply Sirona (NASDAQ: XRAY) reported Q2 2024 results with net sales of $984 million, down 4.2% year-over-year. The company experienced a net loss of $4 million or ($0.02) per share, compared to net income of $86 million in Q2 2023. Adjusted EPS was $0.49, down from $0.51 in the previous year.
Key highlights include:
- Organic sales decreased by 2.3%
- GAAP gross margin of 51.9%
- Adjusted EBITDA margin of 17.5%
- $150 million in share repurchases during Q2
Dentsply Sirona revised its FY24 outlook, now expecting organic sales to be down 1% to flat, and adjusted EPS between $1.96 and $2.02. The company also announced a second phase of transformation, aiming to reduce annualized operating expenses by $80 to $100 million over 12 to 18 months.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on July 31, 2024, at 8:30 am ET to discuss its second-quarter financial results. The presentation will be accessible on the company's investor site. Interested participants can register for the call via a provided link, and a replay will be available post-event.
Dentsply Sirona (Nasdaq: XRAY) has canceled its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions.
The company was initially scheduled to take part on June 13, 2024, at 8:00 am ET.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in two upcoming investor conferences. The company will present at the William Blair 44th Annual Growth Stock Conference on June 5, 2024, at 9:20 am CT and the Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, at 8:00 am ET. Interested parties can access live and replay webcasts via the Dentsply Sirona investor website.
Dentsply Sirona, trading under the Nasdaq symbol XRAY, announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock.
This equates to an annual rate of $0.64 per share. The dividend is scheduled to be paid on July 12, 2024, to shareholders who are on record as of June 28, 2024.
Dentsply Sirona Inc. (XRAY) will participate in the Bank of America 2024 Health Care Conference on May 15, 2024, and the Stifel 2024 Jaws and Paws Conference on May 29, 2024. Investors can access live audio webcasts on the company's website.
Dentsply Sirona reported a decrease in net sales of 2.6% in the first quarter of 2024, with organic sales down 1.9%. The GAAP gross margin was 53.1%, with net income of $18 million or $0.09 per share. Adjusted EBITDA margin was 16.8%, with adjusted EPS of $0.42. The company is maintaining its FY24 outlook but trending towards the low-end of both organic sales and adjusted EPS ranges. Dentsply Sirona plans to repurchase up to $150 million of its common stock in Q2 2024.
FAQ
What is the current stock price of DENTSPLY SIRONA (XRAY)?
What is the market cap of DENTSPLY SIRONA (XRAY)?
What does Dentsply Sirona Inc. do?
What is DS Core?
When was Dentsply Sirona formed?
Where is Dentsply Sirona headquartered?
What event does Dentsply Sirona host annually?
How can I learn more about Dentsply Sirona's products?
What kind of products does Dentsply Sirona offer?
What is the significance of Dentsply Sirona in the dental industry?
How does Dentsply Sirona distribute its products?
What recent updates has Dentsply Sirona announced?
